EP Patent

EP3632208A1 — Cell stabilization

Assigned to Biomatrica Inc · Expires 2020-04-08 · 6y expired

What this patent protects

The present invention relates to stabilization of cells at ambient temperatures. More particularly, the present invention relates to formulations, compositions, kits and methods that allow dehydration and rehydration of cells and dramatically increased recovery of functional cell…

USPTO Abstract

The present invention relates to stabilization of cells at ambient temperatures. More particularly, the present invention relates to formulations, compositions, kits and methods that allow dehydration and rehydration of cells and dramatically increased recovery of functional cells after dry storage at room temperature.

Drugs covered by this patent

Patent Metadata

Patent number
EP3632208A1
Jurisdiction
EP
Classification
Expires
2020-04-08
Drug substance claim
No
Drug product claim
No
Assignee
Biomatrica Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.